The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from Photonics RSS Feed.
An infrared imaging system to detect diabetic peripheral neuropathy (DPN) in patients’ feet, aided by artificial intelligence, has moved closer to use in clinics and hospitals, following the receipt of a three-year, $3 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases. The grant from the institute, which is under the umbrella of the National Institutes of Health, is the continuation of earlier funding used by VisionQuest Biomedical Inc. and the University of New Mexico (UNM) School of Medicine.
The Foundation for Peripheral Neuropathy indicates that over 70% of people with diabetes have DPN, which produces loss of sensation, foot ulcers, and thousands of amputations every year.